Húðlæknar veita ráð um húðvernd

Dermatologists provide tips on skin care.

The UK's

Daily Mail

(4/19, Penman) asked some of "leading dermatologists...what they put on their skin to keep it looking fresh and young." The dermatologists recommended focusing "on cleaning [the] skin without sapping away its natural moisture." Those with dry skin should avoid "over-washing." The dermatologists also suggested using moisturizers that "reinforce the skin's naturally protective oily layer and lock in moisture." They were "united in endorsing sunblocks," recommending products that are "at least factor 15 and...efficient at screening out UVA rays." As for "anti-wrinkle ingredients touted by the cosmetics industry," dermatologist Dr. Sam Bunting said, "They are designed to sit on the surface of the skin -- not penetrate it -- so they don't work. It's as simple as that." Dr. Sue Mayou, spokeswoman for the British Skin Foundation, explained that if cosmetic companies proved categorically that such products did work, then the "products would have to be licensed as medicines," and would have to "be available only on prescription."

Skoðið tengilin hér að ofan. Þar seru sett fram ýmis praktísk ráð varðandi val á kremum fyrir almenna húðhirðu.

Daivobet bætir naglpsoriasis

Calcipotriol plus betamethasone ointment improves symptoms of nail psoriasis, researchers say.

MedWire

(4/3, McDermid) reports that, according to a

study

published online in the journal Dermatology, "a two-compound ointment containing calcipotriol and betamethasone improves the symptoms of patients with nail psoriasis." For the study, researchers from the University of Athens Medical School in Greece "recruited 22 psoriasis patients with mild dermatological symptoms and 114 involved nails," then "treated them with a two-compound calcipotriol plus betamethasone ointment for 12 weeks." Participants "were instructed to apply the ointment at bedtime and to avoid washing their hands until the next morning." The investigators said that "this treatment regimen resulted in a 72 percent reduction in average Nail Psoriasis Severity Index (NAPSI) scores -- from 5.8 at baseline to 1.6 at 12 weeks." In particular, "the ointment was most effective for reducing hyperkeratosis...and onycholysis," and "also caused moderate improvements in oil drops and slight improvements in pitting."
       

Study indicates calcipotriol, betamethasone dipropionate ointment may be more effective for treatment of scalp psoriasis.

MedWire

(4/3, Piper) reports that, according to a

study

published online in the British Journal of Dermatology, a "once-daily combination" regimen of "calcipotriol plus betamethasone dipropionate" appears to be "significantly more effective and better tolerated than twice-daily calcipotriol scalp solution alone for the treatment of scalp psoriasis." For the study, researchers from Denmark's Aarhus University Hospital compared the combination formulation's "clinical efficacy and safety" against "twice-daily calcipotriol, for scalp psoriasis," and found that "significantly more of the 207 patients receiving the two-compound solution reported relief from itching and were 'clear' of psoriasis or had 'minimal disease' after eight weeks of treatment than the 105 receiving calcipotriol, at 68.6...versus 31.4 percent." Moreover, "improvement was rapid with a significant difference evident as early as week two." The authors noted, however, "that maintenance therapy with the two-compound scalp formulation may be necessary after observing a relapse rate of 54.1 percent."

Bretar vilja þrengja reglugerðir vegna ljósbekkja eftir að ung stúlka brennur illa

Sunbed campaign targets schools

Schoolchildren are being given the chance to quiz skin cancer experts and victims over the dangers of sunbeds. The Sunsmart campaign was launched at Bishop Gore Comprehensive in Swansea and will visit other schools in Wales. It follows the case of Kirsty McRae who suffered 70% burns on her body and ended up on a drip in hospital after using a coin-operated sunbed in Barry.........

Calls to staff all tanning salons

Calls for unstaffed tanning salons to be banned after a 14-year-old burnt over 70% of her body have been made by dermatologists and politicians. A health and safety inquiry is underway into Kirsty McRae's 19-minute use of the salon in Barry, Vale of Glamorgan. Swansea East MP Sian James said the case was the "tip of the iceberg" of youngsters using such salons. Salon owner James Hadley said he actively tried to discourage under-16s from using his shop.Kirsty, from Barry Island, Vale of Glamorgan, said she took full responsibility for using the unstaffed ..........

Rannsóknir benda til að unglingabólur séu tengdar x-litningnum

Study indicates risk for acne may be linked with X chromosome.

MedWire

(3/27, Wilkinson) reported that, according to a study published in the Journal of Investigative Dermatology, "the risk for acne may be linked with the X chromosome." For the study, researchers from the Dessau Medical Center in Germany examined "risk factors for acne vulgaris among 1,002 Iranian pupils in Tehran, of whom 499 were boys and 503 were girls. The mean age of participants in the cross-sectional study was 16 years." The team found that the "risk for suffering moderate-to-severe acne increased with the number of affected immediate members of the family." Notably, "the mother's acne history was more important in determining its severity than the father's," with both being "more influential in determining acne severity than brothers or sisters." The authors also found that "moderate-to-severe acne was...associated with the premenstrual phase, mental stress, and eating sweet and oily foods, but not with gender, spicy foods, or smoking overall."

Sólbruni og fjölskyldusaga auka líkur á rósroða

Study implicates sunburn, family history in rosacea.

HealthDay

(3/10, McKeever) reported that, according to a study presented at the annual meeting of the American Academy of Dermatology, "people with the reddening skin condition rosacea tend to have a family history of the disease and a personal history of sunburns." Researchers from Harvard Medical School found that, in a "study of 130 people, half with moderate to severe rosacea and half without, 34 percent of those with the disease reported having a relative who also had the skin disorder, whereas only about 10 percent of those without the disease had it in their family." In addition, the team "found that 44 percent of people with rosacea reported having had blistering sunburns at some time, compared with just more than five percent of the others." The authors recommended that "people who have a family history of rosacea," particularly "children...regularly use broad-spectrum sunscreen and use other sun protection measures."

Lasermeðferð virkar vel á Psoriasis

Excimer laser seen as effective treatment for small areas of psoriasis.

In the

Wall Street Journal

(3/17, D6) Aches & Claims column, Laura Johannes observed that the "excimer laser, best known for its use in eye surgery, is now being used to treat psoriasis," and "is extremely effective for small areas affected by the skin disease -- such as a knee or elbow." The device uses "an ultraviolet light wavelength...and a handheld wand that allows the energy to be delivered precisely to the affected areas." Because "small areas are usually involved, more intense light can be used to effectively treat the areas with twice-a-week visits for only five weeks." The painless procedure, which is "typically performed in a dermatologist's office," usually "takes three to five minutes," and "costs $160 or more per visit." A "124-patient

study

...published in the Journal of the American Academy of Dermatology," found that "84 percent" of patients who completed the study "showed at least a 75 percent improvement on a scale of psoriasis severity in 10 or fewer treatments."

Lágir skammtar af Neotigason bæta naglpsoriasis

Low-dose acitretin therapy may reduce nail psoriasis, research suggests.

HealthDay

(3/17, Preidt) reported that, according to a

study

published in the March issue of the Archives of Dermatology, "low-dose treatment with" acitretin, "a drug used to treat skin psoriasis, seems to help reduce nail psoriasis." For the study, researchers from Italy's University of Bologna "evaluated the effect of low-dose acitretin therapy (0.2 to 0.3 milligrams per kilogram per day for six months) on the nails of 27 men and nine women...with nail psoriasis." The team followed patients "for at least six months after treatment," and used "the Nail Psoriasis Severity Index...to grade the severity of their condition." After six months, "clinical evaluation" revealed "complete or almost complete clearing of the nail lesions in nine patients (25 percent), moderate improvement in nine (25 percent), mild improvement in 12 (33 percent), and no improvement in six (11 percent)."